Stonepine Capital Management, LLC - Significant Ownership

Signature - Title
Jon M. Plexico - Managing Member
Location
Bend, OR
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Stonepine Capital Management, LLC.

Significant Ownership of Stonepine Capital Management, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EDSA Edesa Biotech, Inc. Common Stock 9.9% $1.65M 694K Stonepine Capital Management, LLC Feb 13, 2025
TELA TELA Bio, Inc. Common Stock 6% $6.33M 2.35M Stonepine Capital Management, LLC Dec 31, 2024
OPTN OptiNose, Inc. Common Stock 5.9% $3.18M 589K Stonepine Capital Management, LLC Dec 31, 2024
CALC CalciMedica, Inc. Common Stock, par value $0.0001 per share 5.4% $1.42M 742K Stonepine Capital Management, LLC Dec 6, 2024
INO Inovio Pharmaceuticals, Inc. Common Stock 5.2% $3.7M 1.92M Stonepine Capital Management, LLC Dec 17, 2024
APRE Aprea Therapeutics, Inc. Common Stock 5.1% $693K 286K Stonepine Capital Management, LLC Dec 31, 2024
VSTM Verastem, Inc. Common Stock 4.8% $15.9M 2.2M Stonepine Capital Management, LLC Dec 31, 2024

Schedules 13D/G Reported by Stonepine Capital Management, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.